Modulating Glycolysis to Improve Cancer Therapy.
Chelakkot C, Chelakkot VS, Shin Y, Song K. · 2023
Read Modulating Glycolysis to Improve Cancer Therapy. by Chelakkot C, Chelakkot VS, Shin Y, Song K. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9916680.txt.
Description
Chelakkot and co-authors explore how changing glycolysis could improve cancer therapy. Cancer cells shift to a glycolysis-dominant profile to gain energy and building blocks. This shift is known as the Warburg effect. It also makes the tumor setting more pro-cancer and raises drug and radiation resistance.
Immune cells in tumors make a like shift, so both cell types compete for nutrients. Blocking high glycolysis may leave cancer cells open to other treatments. Options include chemotherapy, radiotherapy, hormone therapy, immunotherapy, and photodynamic therapy. Many targeting tactics sit in preclinical or clinical testing. Few yet hit cancer glycolysis with enough precision. The review weighs what is known and what still blocks progress.
Catalog record
| CREATOR | Chelakkot C, Chelakkot VS, Shin Y, Song K. |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 162 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |